GKB Ophthalmics Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The Goa-based pharmaceutical company filed the mandatory documentation for the quarter ended March 31, 2026, demonstrating continued adherence to securities market regulations.

Regulatory Compliance Filing

The company submitted its certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, on April 07, 2026. Company Secretary Pooja Dessai née Bicholkar signed and submitted the documentation to BSE Limited's Department of Corporate Services.

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, provided the confirmation certificate as the company's registrar and transfer agent. The registrar confirmed that all securities received from depository participants for dematerialisation during the quarter ended March 31, 2026, were properly processed and confirmed to the depositories.

Compliance Confirmation

The registrar confirmed several key compliance aspects in their certificate:

• Securities received for dematerialisation were confirmed or rejected within prescribed timelines
• Security certificates were properly mutilated and cancelled after verification
• Depository names were substituted in the register of members as registered owners
• All securities comprised in the certificates have been listed on stock exchanges where earlier issued securities are listed

Company Information

GKB Ophthalmics Limited operates from its facility at 16-A, Tivim Industrial Estate, Mapusa, Goa. The company, incorporated in 1981 with CIN L26109GA1981PLC000469, has been in operation since 1960 and maintains its corporate compliance through regular regulatory filings with stock exchanges and regulatory authorities.

GKB Ophthalmics Ltd has submitted a regulatory disclosure to BSE Limited confirming that its promoters and promoter group have not encumbered any shares during the financial year ended March 31, 2026. The disclosure was filed on April 02, 2026, in compliance with SEBI Takeover Regulations.

Regulatory Compliance Details

The disclosure was made under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011. This regulation requires promoters to confirm the status of share encumbrances at the end of each financial year.

Promoter Declaration

Krishna Gopal Gupta, acting on behalf of the promoter group, confirmed that no encumbrance of shares was made directly or indirectly during the specified financial year. The declaration covers all promoters, promoter group members, and persons acting in concert with GKB Ophthalmics Limited.

Corporate Information

GKB Ophthalmics Limited is headquartered at 16-A, Tivim Industrial Estate, Mapusa, Goa 403526. The company secretary Pooja Bicholkar facilitated the regulatory filing process. The disclosure was also copied to the company's Audit Committee as part of internal governance procedures.

Significance of Disclosure

This regulatory filing ensures transparency in promoter shareholding and compliance with SEBI's takeover regulations. The confirmation of no share encumbrances provides clarity to investors and stakeholders regarding the promoter group's shareholding status during FY26.